Solutia's two-year-old pharmaceutical services division,based at Famborough,U.K.,says it will build a high-potency active ingredients (HPAI) operation at Marly,Switzerland for startup early nex tyear.The division,formed via the acquistitions of CarboGen and Amcis in 2000,reported sales of
展开▼
